Showing results (221-230 of 267) with videos related to
Sort By:
Pageof 27
Radiation Oncology (London, England)|November 8, 2011
Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/mlRei Umezawa, Hisanori Ariga, Yoshihiro Ogawa, et al.Plos One|December 2, 2022
Longitudinal analyses and predictive factors of radiation-induced lung toxicity-related parameters after stereotactic radiotherapy for lung cancerTakaya Yamamoto, Yoshiyuki Katsuta, Kiyokazu Sato, et al.Journal of Radiation Research|May 9, 2026
Feasibility of retrieval-augmented generation for large language models with Japanese input in radiotherapyYoshiyuki Takahashi, Noriyuki Kadoya, Kazuhiro Arai, et al.BMC Cancer|April 5, 2022
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practiceTakaya Yamamoto, Yoko Tsukita, Yu Katagiri, et al.Journal of Radiation Research|September 1, 2021
Clinical predictors of severe late urinary toxicity after curative intensity-modulated radiation therapy for localized prostate cancerKen Takeda, Rei Umezawa, Yojiro Ishikawa, et al.Journal of Radiation Research|March 7, 2025
Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)Toshiya Maebayashi, Takashi Mizowaki, Hitoshi Ishikawa, et al.Advances in Radiation Oncology|December 11, 2020
Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging StudyRei Umezawa, Noriyuki Kadoya, Hideki Ota, et al.Radiation Oncology (London, England)|May 28, 2016
Renal atrophy after stereotactic body radiotherapy for renal cell carcinomaTakaya Yamamoto, Noriyuki Kadoya, Ken Takeda, et al.The Tohoku Journal of Experimental Medicine|November 13, 2015
Radiation Therapy Is a Reasonable Option for Improving the Prognosis in Hepatocellular CarcinomaYasuteru Kondo, Osamu Kimura, Takayuki Kogure, et al.Anticancer Research|May 7, 2017
Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal CancerKeiichi Jingu, Yukinori Matsuo, Hiroshi Onishi, et al.Pageof 27